bisoprolol has been researched along with Dermatitis Medicamentosa in 3 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Asano, A | 1 |
Nakai, K | 1 |
Tsuruta, D | 1 |
Higashiyama, A | 1 |
Yokoyama, T | 1 |
Omoto, Y | 1 |
Habe, K | 1 |
Yamanaka, K | 1 |
Mizutani, H | 1 |
Giner Esparza, MA | 1 |
Miedes Pitarch, E | 1 |
Miquel Miquel, FJ | 1 |
Palop Larrea, V | 1 |
3 other studies available for bisoprolol and Dermatitis Medicamentosa
Article | Year |
---|---|
Lichenoid drug eruption associated with bisoprolol transdermal patches.
Topics: Administration, Cutaneous; Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Delayed-Action Prepar | 2022 |
Flutamide-induced photoleukomelanoderma.
Topics: Administration, Cutaneous; Aged; Androgen Antagonists; Benzimidazoles; Biopsy; Biphenyl Compounds; B | 2016 |
[Fixed drug eruption and bisoprolol].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Drug Eruptions; Female; Humans; Middle Aged | 2009 |